Mainstream

Astellas Pharma Non Gaap Eps Of ¥124.60, Revenue Of ¥1453.03b; Updates Fy Outlook

Astellas Pharma Non-GAAP EPS of ¥124.60, revenue of ¥1453.03B; updates FY outlook

Astellas Pharma Non-GAAP EPS of ¥124.60, revenue of ¥1453.03B; updates FY outlook

Post Contentalpmf, alpmyRead More

You might also be interested in reading SoFi rolls out ‘Big Business Banking’ to fuse fiat and crypto rails.

February 4, 2025
In Mainstream